Muenst S - Search Results

1

Multiparameter analysis of homogeneously R-CHOP-treated diffuse large B cell lymphomas identifies CD5 and FOXP1 as relevant prognostic biomarkers: report of the prospective SAKK 38/07 study.

Tzankov A, Leu N, Muenst S, Juskevicius D, Klingbiel D, Mamot C, Dirnhofer S. Tzankov A, et al. Among authors: muenst s. J Hematol Oncol. 2015 Jun 14;8:70. doi: 10.1186/s13045-015-0168-7. J Hematol Oncol. 2015. PMID: 26071053 Free PMC article.

2

Increased programmed death-1+ tumor-infiltrating lymphocytes in classical Hodgkin lymphoma substantiate reduced overall survival.

Muenst S, Hoeller S, Dirnhofer S, Tzankov A. Muenst S, et al. Hum Pathol. 2009 Dec;40(12):1715-22. doi: 10.1016/j.humpath.2009.03.025. Epub 2009 Aug 19. Hum Pathol. 2009. PMID: 19695683

3

Distribution of PD-1+ lymphocytes in reactive lymphadenopathies.

Muenst S, Dirnhofer S, Tzankov A. Muenst S, et al. Pathobiology. 2010;77(1):24-7. doi: 10.1159/000272951. Epub 2010 Feb 25. Pathobiology. 2010. PMID: 20185964 Free article.

4

Diagnostic and prognostic utility of PD-1 in B cell lymphomas.

Muenst S, Hoeller S, Willi N, Dirnhofera S, Tzankov A. Muenst S, et al. Dis Markers. 2010;29(1):47-53. doi: 10.3233/DMA-2010-0725. Dis Markers. 2010. PMID: 20826917 Free PMC article.

5

Frequency, phenotype, and genotype of minute gastrointestinal stromal tumors in the stomach: an autopsy study.

Muenst S, Thies S, Went P, Tornillo L, Bihl MP, Dirnhofer S. Muenst S, et al. Hum Pathol. 2011 Dec;42(12):1849-54. doi: 10.1016/j.humpath.2011.01.024. Epub 2011 Jun 12. Hum Pathol. 2011. PMID: 21658742

6

Author's response to "Letter to the editor: unvalidated antibodies and misleading results".

Muenst S, Tzankov A, Gillanders WE, Soysal SD. Muenst S, et al. Breast Cancer Res Treat. 2014 Sep;147(2):459-62. doi: 10.1007/s10549-014-3064-x. Breast Cancer Res Treat. 2014. PMID: 25082517 No abstract available.

7

The PD-1/PD-L1 pathway: biological background and clinical relevance of an emerging treatment target in immunotherapy.

Muenst S, Soysal SD, Tzankov A, Hoeller S. Muenst S, et al. Expert Opin Ther Targets. 2015 Feb;19(2):201-11. doi: 10.1517/14728222.2014.980235. Epub 2014 Dec 10. Expert Opin Ther Targets. 2015. PMID: 25491730 Review.

8

Role of the Tumor Microenvironment in Breast Cancer.

Soysal SD, Tzankov A, Muenst SE. Soysal SD, et al. Pathobiology. 2015 Sep;82(3-4):142-52. doi: 10.1159/000430499. Epub 2015 Aug 31. Pathobiology. 2015. PMID: 26330355 Review.

9

The immune system and cancer evasion strategies: therapeutic concepts.

Muenst S, Läubli H, Soysal SD, Zippelius A, Tzankov A, Hoeller S. Muenst S, et al. J Intern Med. 2016 Jun;279(6):541-62. doi: 10.1111/joim.12470. Epub 2016 Jan 8. J Intern Med. 2016. PMID: 26748421 Free article. Review.

10

Ex-vivo assessment of drug response on breast cancer primary tissue with preserved microenvironments.

Muraro MG, Muenst S, Mele V, Quagliata L, Iezzi G, Tzankov A, Weber WP, Spagnoli GC, Soysal SD. Muraro MG, et al. Among authors: muenst s. Oncoimmunology. 2017 May 30;6(7):e1331798. doi: 10.1080/2162402X.2017.1331798. eCollection 2017. Oncoimmunology. 2017. PMID: 28811974 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

60 results

Search Page

Filters